Keywords: novartis, licenses, iloperidone, titan, signed, agreement, pharmaceuticals

Novartis Licenses Iloperidone From Titan

Article | 21 November 1997

Print This

Novartis has signed an agreement with Titan Pharmaceuticals of the USAfor worldwide rights to iloperidone, a new antipsychotic agent in ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in